MALAT1 and Alzheimer disease: In contrary, by comparing 120 Alzheimer’s disease patients with 120 control individuals with neurological but not neurodegenerative disorders, Zhuang et al. found downregulation of MALAT1 in cerebrospinal fluid and plasma samples from AD patients, which was associated with advanced disease severity [136].